Insitro picks up Series B
South San Francisco-based Insitro, a machine-learning driven drug discovery and development company, has raised US$143 million in Series B financing.
South San Francisco-based Insitro, a machine-learning driven drug discovery and development company, has raised US$143 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination
